I posted this days ago as well:
WOW!!! They are in several licensing negotiations, via MS. I taste income!!!!!!
Sound like bacteria doesn't even have a chance, with CYGX's technology. Herpes is first and bacteria is second. They have more than one bacterial product, like sterilizing the surgical field and topical treatments.
The DNA vaccine, it appears large pharma has moved away from anitbiotics and DNA vaccines. With new approaches from CYGX, different groups have been contacted by CYGX to help them bring new products to market.
All the parts are all coming into place. They have acquired staff and are building their DNA plant and are reviewing the first phase studies and have staff already for it and need more.
This sounds great, I am getting even more excited!!!
I'm suprised no one else picked up the ball and ran with this. This is huge news, just huge.
If we can get some licensing agreements with some major players we will have a huge spike in our PPS.